NIH and Office of Dietary Supplements grants HL103866, HL126827, and DK106000, and the Leducq Foundation
Isabel Krug et al., Beyond Weight Loss: GLP1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes , 17 Nutrients 3735, 5 (2025), available at : (last visited Apr
The incretin effect It is a well-known fact that oral administration of glucose is a more potent stimulus for insulin secretion than parenteral infusion [8]
LeviaPatch's own FAQ states clearly that the patches do not contain prescription GLP-1 drugs such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)
And beyond that, I have a lot of patients who have avoided taking insulin because of their fear of needles
And understandably so, given that they represent the first true improvement on the issue